Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05799222 · ClinicalTrials.gov registry record
Medically Intensive Nutrition Therapy Program for Obesity and Diabetes in a Low-income Population
A clinical trial of Obesity and Overweight, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT05799222 is a study of Obesity and Overweight that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 20 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05799222, a study of Obesity and Overweight, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being done to better understand whether meal replacements can be an effective tool for weight loss and treatment of elevated blood sugars in people with obesity/overweight and diabetes/pre-diabetes who have a low income.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Bariatrix Meal Replacement Products
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2023-03-28 |
| Est. Completion | 2026-11-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05799222
The ClinicalTrials.gov registry entry for NCT05799222 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (98% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Bariatrix Meal Replacement Products is the first listed.
NCT05799222 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05799222 about?
NCT05799222 is a clinical study titled "Medically Intensive Nutrition Therapy Program for Obesity and Diabetes in a Low-income Population". This study is being done to better understand whether meal replacements can be an effective tool for weight loss and treatment of elevated blood sugars in people with obesity/overweight and diabetes/pre-diabetes who have a low income.
What is the current status of trial NCT05799222?
This trial is currently recruiting. The enrollment target is 20 participants. The study started on 2023-03-28. Estimated completion is 2026-11-10.
What conditions does trial NCT05799222 study?
This clinical trial studies the following conditions: Obesity, Overweight, PreDiabetes, Diabetes Type 2.
What interventions are being tested in trial NCT05799222?
The interventions under investigation include: Bariatrix Meal Replacement Products (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05799222?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05799222 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
RECRUITING · Phase 1
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.